TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11358726

Group type: EXPERIMENTAL
Intervention: Montelukast 10 mg/day
Number of subjects: 32

Group type: COMPARATOR
Intervention: Combined regimen (cetirizine, clarythromycin, topical corticosteroids, hydrating preparations)
Number of subjects: 32
Study: 9145693

Group type: EXPERIMENTAL
Intervention: Ophthalmic fluorometholone-gentamicin
Number of subjects: 70

Group type: COMPARATOR
Intervention: Ophthalmic betamethasone-gentamicin
Number of subjects: 70
Study: 8174531

Group type: EXPERIMENTAL
Intervention: Thiopentone
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Thiopentone/Ketamine
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 75
Study: 3064776

Group type: EXPERIMENTAL
Intervention: Postmastectomy irradiation + CMF (cyclophosphamide, methotrexate, 5-fluorouracil)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Postmastectomy irradiation + TAM (tamoxifen)
Number of subjects: 0

Group type: COMPARATOR
Intervention: CMF alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CMF + TAM
Number of subjects: 0

Group type: COMPARATOR
Intervention: TAM alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Irradiated patients (both pre- and postmenopausal)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Adjuvant systemic treatment alone (chemotherapy and/or tamoxifen)
Number of subjects: 0
Study: 31895881

Group type: EXPERIMENTAL
Intervention: wSp 0.1 mg
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: wSp 0.3 mg
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: wSp 0.6 mg
Number of subjects: 42

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 42
Study: 30243202

Group type: EXPERIMENTAL
Intervention: Use of a minimally invasive catheter for ETT positioning
Number of subjects: 69

Group type: COMPARATOR
Intervention: Without the catheter
Number of subjects: 69
Study: 26797698

Group type: EXPERIMENTAL
Intervention: Double-row (DR) repair
Number of subjects: 58

Group type: COMPARATOR
Intervention: Single-row (SR) repair
Number of subjects: 58
Study: 24314016

Group type: EXPERIMENTAL
Intervention: Oral prophylaxis with tongue cleaning
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 30
Study: 22411724

Group type: EXPERIMENTAL
Intervention: Heated cannabis extract
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Unheated cannabis extract
Number of subjects: 9

Group type: COMPARATOR
Intervention: Synthetic THC (dronabinol)
Number of subjects: 9
Study: 20425166

Group type: EXPERIMENTAL
Intervention: Combination of simvastatin and ezetimibe
Number of subjects: 1873

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1873
Study: 18077786

Group type: EXPERIMENTAL
Intervention: enalapril
Number of subjects: 60

Group type: COMPARATOR
Intervention: atenolol
Number of subjects: 60
Study: 16897905

Group type: EXPERIMENTAL
Intervention: Music therapist playing and singing continually to the child
Number of subjects: 17

Group type: COMPARATOR
Intervention: Switch-activated pig toy
Number of subjects: 17

Group type: COMPARATOR
Intervention: Switch-activated recorded music
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Music therapist playing and singing contingent upon child touching the guitar
Number of subjects: 17
Study: 12923133

Group type: EXPERIMENTAL
Intervention: CDB-2914 at doses of 1-100 mg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: CDB-2914 at 200 mg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: CDB-2914 at doses of 10, 50, 100 and 200 mg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: CDB-2914
Number of subjects: 36
Study: 12212206

Group type: EXPERIMENTAL
Intervention: Simvastatin 20 mg.d-1
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control (no simvastatin)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 47
Study: 8831319

Group type: EXPERIMENTAL
Intervention: Transcutaneous cranial electrical stimulation (TCES)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (no TCES)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Both groups (TCES and Control)
Number of subjects: 39
Study: 8488308

Group type: EXPERIMENTAL
Intervention: Specialized AIDS education program (S)
Number of subjects: 858

Group type: COMPARATOR
Intervention: Traditional AIDS education program (T)
Number of subjects: 858

Group type: EXPERIMENTAL
Intervention: Both programs (S and T)
Number of subjects: 858
Study: 3545116

Group type: EXPERIMENTAL
Intervention: Ketanserin
Number of subjects: 18

Group type: COMPARATOR
Intervention: Metoprolol
Number of subjects: 18

Group type: COMPARATOR
Intervention: Ketanserin vs Metoprolol
Number of subjects: 18
Study: 30193571

Group type: EXPERIMENTAL
Intervention: Active warming (AW) with a forced-air warming system
Number of subjects: 62

Group type: COMPARATOR
Intervention: Passive warming (PW) with application of a cotton blanket
Number of subjects: 62
Study: 27177805

Group type: EXPERIMENTAL
Intervention: HAT + CM
Number of subjects: 214

Group type: COMPARATOR
Intervention: HAT-only
Number of subjects: 214
Study: 23163982

Group type: EXPERIMENTAL
Intervention: NCLF‐US thrice per week (Group 1)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: NCLF‐US once per week (Group 2)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (Group 3)
Number of subjects: 12
Study: 23650900

Group type: EXPERIMENTAL
Intervention: NAV (Freestyle® Navigator I)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: ENL (Paradigm® with Enlite™ sensor)
Number of subjects: 20

Group type: COMPARATOR
Intervention: G4A (Dexcom® G4™ version A sensor)
Number of subjects: 20
Study: 20876317

Group type: EXPERIMENTAL
Intervention: Preoperative chemoradiotherapy followed by postoperative chemotherapy
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Nuclear p-STAT3 expression
Number of subjects: 104
Study: 18361816

Group type: EXPERIMENTAL
Intervention: Adhesion releasing under brachial plexus block
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Adhesion releasing under stellate ganglion block
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Limited adhesion releasing under stellate ganglion block
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Arthrolysis under stellate ganglion block
Number of subjects: 60

Group type: COMPARATOR
Intervention: Block + manipulation treatment (Group I)
Number of subjects: 60
Study: 16178642

Group type: EXPERIMENTAL
Intervention: ET-OCT-V
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: ET-OCT-M
Number of subjects: 16
Study: 12663299

Group type: EXPERIMENTAL
Intervention: High-fiber rye foods
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: High-fiber wheat foods
Number of subjects: 28

Group type: COMPARATOR
Intervention: Low-fiber refined-cereal foods
Number of subjects: 28
Study: 10994616

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg b.d. for 2 weeks
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (healthy subjects)
Number of subjects: 29
Study: 8772566

Group type: EXPERIMENTAL
Intervention: Episodic GHRH administration (200 micrograms, 4 boluses of 50 micrograms each at 2200, 2300, 2400, and 0100 h)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Continuous GHRH infusion (57 micrograms/h between 2130 and 0100 h)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 1290611

Group type: EXPERIMENTAL
Intervention: Microfilled resin
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Hybrid resins
Number of subjects: 161

Group type: COMPARATOR
Intervention: All resins (microfilled and hybrid)
Number of subjects: 161
Study: 3158254

Group type: EXPERIMENTAL
Intervention: 80 micrograms/kg atracurium
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 100 micrograms/kg atracurium
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 150 micrograms/kg atracurium
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Atracurium steady-state infusion during halothane or isoflurane anesthesia
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Atracurium steady-state infusion during balanced anesthesia
Number of subjects: 15
Study: 30168810

Group type: EXPERIMENTAL
Intervention: Angina Self-Management (ASM) intervention (n = 39)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Attention-control telephone call (n = 41)
Number of subjects: 80
Study: 26673811

Group type: EXPERIMENTAL
Intervention: Ibrutinib (560 mg daily)
Number of subjects: 280

Group type: COMPARATOR
Intervention: Temsirolimus (175 mg on days 1, 8, and 15 of cycle 1; 75 mg on days 1, 8, and 15 of subsequent cycles)
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Ibrutinib
Number of subjects: 280

Group type: COMPARATOR
Intervention: Temsirolimus
Number of subjects: 280
Study: 23812324

Group type: COMPARATOR
Intervention: Conventional colonoscopy
Number of subjects: 1069

Group type: COMPARATOR
Intervention: Latest generation HDTV colonoscopy
Number of subjects: 1069

Group type: COMPARATOR
Intervention: Image-based recommendations for post-polypectomy surveillance
Number of subjects: 1069

Group type: COMPARATOR
Intervention: Post hoc analysis of polyp photographs
Number of subjects: 1069
Study: 22419603

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 20111953

Group type: EXPERIMENTAL
Intervention: Intra-articular polynucleotides (n = 30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Hyaluronan (n = 30)
Number of subjects: 60
Study: 18522727

Group type: EXPERIMENTAL
Intervention: Moderate dose of cognac (1.2 +/- 0.1 dl)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: High dose of cognac (2.4 +/- 0.3 dl)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control day
Number of subjects: 23
Study: 16265683

Group type: EXPERIMENTAL
Intervention: Phase III RCT with adequate sample size
Number of subjects: 228

Group type: COMPARATOR
Intervention: Negative RCT with inadequate sample size
Number of subjects: 228

Group type: COMPARATOR
Intervention: Negative RCT
Number of subjects: 228

Group type: COMPARATOR
Intervention: Phase III trials without power calculations
Number of subjects: 228
Study: 12438009

Group type: EXPERIMENTAL
Intervention: Oral contraceptives (OC)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Pregnant women
Number of subjects: 18
Study: 10050702

Group type: EXPERIMENTAL
Intervention: tinzaparin (4500 anti-Xa IU)
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: enoxaparin (40 mg, 4000 anti-Xa IU)
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: tinzaparin
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: tinzaparin and enoxaparin
Number of subjects: 440
Study: 7486040

Group type: EXPERIMENTAL
Intervention: Thiamylal (4.0‐5.0 mg/kg)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Ketamine (1.5‐2.0 mg/kg)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Succinylcholine (1.0 mg/kg) - Control Group O
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control Group O
Number of subjects: 90
Study: 2077498

Group type: COMPARATOR
Intervention: Combination of chloral hydrate and hydroxyzine (placebo control)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Chloral hydrate (three doses)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 6778329

Group type: EXPERIMENTAL
Intervention: Antihistamine-adrenergic combination (diphenhydramine and pseudoephedrine)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 31763948

Group type: EXPERIMENTAL
Intervention: Ejaculatory hood sparing vaporization
Number of subjects: 49

Group type: COMPARATOR
Intervention: Standard prostate vaporization
Number of subjects: 49
Study: 30345635

Group type: EXPERIMENTAL
Intervention: OCT-guided PCI with automated coregistration
Number of subjects: 200

Group type: COMPARATOR
Intervention: OCT-guided PCI without automated coregistration
Number of subjects: 200
Study: 28117242

Group type: EXPERIMENTAL
Intervention: Coronary computed tomography angiography (CTA)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Angiography alone (CA)
Number of subjects: 92
Study: 25541338

Group type: EXPERIMENTAL
Intervention: Topical tranexamic acid 1.5 g in povidone-iodine solution (group B)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Topical tranexamic acid 3.0 g in povidone-iodine solution (group C)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Povidone-iodine solution (control: group A)
Number of subjects: 125
Study: 23773380

Group type: EXPERIMENTAL
Intervention: Completion axillary lymph node dissection (cALND)
Number of subjects: 474

Group type: EXPERIMENTAL
Intervention: Regional nodal irradiation (RNI)
Number of subjects: 474
Study: 21389184

Group type: EXPERIMENTAL
Intervention: Cola
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Diet Cola
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Mineral Water
Number of subjects: 16
Study: 19203565

Group type: EXPERIMENTAL
Intervention: Clarithromycin (CLR) 500 mg oral dose (Group 1: Merck; Group 2: Klaricid)
Number of subjects: 0
Study: 17381500

Group type: EXPERIMENTAL
Intervention: Insulin detemir (twice daily)
Number of subjects: 320

Group type: COMPARATOR
Intervention: Insulin glargine (once daily)
Number of subjects: 320
Study: 14988471

Group type: COMPARATOR
Intervention: Calcium supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dairy products
Number of subjects: 0
Study: 11481926

Group type: EXPERIMENTAL
Intervention: Test Dentifrice (0.243% sodium fluoride and dicalcium phosphate dihydrate)
Number of subjects: 2506

Group type: COMPARATOR
Intervention: Positive Control Dentifrice (0.243% sodium fluoride in a silica base)
Number of subjects: 2506

Group type: EXPERIMENTAL
Intervention: Test Dentifrice
Number of subjects: 2506

Group type: COMPARATOR
Intervention: Positive Control Dentifrice
Number of subjects: 2506
Study: 9722821

Group type: EXPERIMENTAL
Intervention: Enhanced (outreach-assisted) intervention
Number of subjects: 60

Group type: COMPARATOR
Intervention: Minimal (self-tell) intervention
Number of subjects: 60
Study: 8068588

Group type: EXPERIMENTAL
Intervention: 400 mg of metronidazole three times daily for 5 days
Number of subjects: 62

Group type: COMPARATOR
Intervention: 400 mg of metronidazole twice daily for 5 days
Number of subjects: 62
Study: 2743379

Group type: EXPERIMENTAL
Intervention: Toothpaste containing 2,500 ppm F
Number of subjects: 16

Group type: COMPARATOR
Intervention: Toothpaste containing 1,500 ppm F
Number of subjects: 16
Study: 1273228

Group type: EXPERIMENTAL
Intervention: Backup reinforcement condition (feedback plus choice of money or extra experimental credit)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Conventional feedback condition
Number of subjects: 80

Group type: COMPARATOR
Intervention: Yoked control condition (received bogus feedback)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control condition (received no feedback)
Number of subjects: 80
Study: 31126306

Group type: EXPERIMENTAL
Intervention: Creatine and electrolyte formulated multi‐ingredient performance supplement (MIPS)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 29035384

Group type: EXPERIMENTAL
Intervention: Anthelmintic treatment
Number of subjects: 0
Study: 26454528

Group type: EXPERIMENTAL
Intervention: Tympanostomy tube placement with adenoidectomy (Group II)
Number of subjects: 137

Group type: COMPARATOR
Intervention: Tympanostomy tube placement without adenoidectomy (Group I)
Number of subjects: 137
Study: 24495636

Group type: EXPERIMENTAL
Intervention: Pressure therapy (PT)
Number of subjects: 20
Study: 21467539

Group type: EXPERIMENTAL
Intervention: Threat conditions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gender stereotypes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High legitimation of sociopolitical system
Number of subjects: 0
Study: 18632424

Group type: EXPERIMENTAL
Intervention: Pravastatin 40 mg per day for nine days, starting 48 hours before CPB, with an additional dose of 40 mg one hour after surgery
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (no pravastatin)
Number of subjects: 43
Study: 16701183

Group type: EXPERIMENTAL
Intervention: Radial plus musculocutaneous nerve stimulation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Ulnar plus musculocutaneous nerve stimulation
Number of subjects: 60
Study: 12944447

Group type: EXPERIMENTAL
Intervention: gum elastic bougie
Number of subjects: 60

Group type: COMPARATOR
Intervention: stylet
Number of subjects: 60
Study: 10840172

Group type: EXPERIMENTAL
Intervention: Zolmitriptan 2.5 mg
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 9375951

Group type: EXPERIMENTAL
Intervention: β-blocker therapy
Number of subjects: 0
Study: 8238159

Group type: EXPERIMENTAL
Intervention: Piperacillin 3 gm intravenously every 6 hours for 72 hours
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 3514224

Group type: EXPERIMENTAL
Intervention: N 10 mg six times daily
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: V 80 mg three times daily
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: ISDN 10 mg six times daily
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: N 20 mg six times daily
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: V 120 mg four times daily
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: ISDN 20 mg six times daily
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: N r 20 mg four times daily
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: V r 120 mg three times daily
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: ISDN sr 40 mg four times daily
Number of subjects: 29
Study: 30883414

Group type: EXPERIMENTAL
Intervention: General anesthesia exposure
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Observational cohort studies
Number of subjects: 131
Study: 30414448

Group type: EXPERIMENTAL
Intervention: Automated, personalized worksite intervention combining environmental strategy (traffic‐light labeling) with objective feedback and personalized nudges (health/lifestyle tips, social norms, incentives)
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: Automated, personalized worksite intervention
Number of subjects: 602
Study: 26230902

Group type: EXPERIMENTAL
Intervention: PDX/GOS (formula with 4 g/L of PDX/GOS)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Control (cow's milk-based formula)
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: BF (breast-fed)
Number of subjects: 157
Study: 23980535

Group type: EXPERIMENTAL
Intervention: 4-week group psychoeducational programme (n = 36)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Control group (n = 35)
Number of subjects: 71
Study: 22378725

Group type: EXPERIMENTAL
Intervention: Capsinoids (9 mg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 20125159

Group type: EXPERIMENTAL
Intervention: High-dose methotrexate (HD-MTX)
Number of subjects: 55

Group type: COMPARATOR
Intervention: High-dose methotrexate (HD-MTX) and high-dose cytarabine (HD-AraC)
Number of subjects: 55
Study: 17347177

Group type: EXPERIMENTAL
Intervention: Gentamicin (7.5 mg/kg, intramuscular, once daily)
Number of subjects: 34
Study: 15963201

Group type: EXPERIMENTAL
Intervention: Thiocolchicoside (TCC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tizanidine (TZ)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 14612224

Group type: EXPERIMENTAL
Intervention: Nortriptyline
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 241

Group type: COMPARATOR
Intervention: Paroxetine and interpersonal psychotherapy
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Anxious group
Number of subjects: 241

Group type: COMPARATOR
Intervention: Nonanxious group
Number of subjects: 241
Study: 10584136

Group type: EXPERIMENTAL
Intervention: Amifostine (500 mg, day 1 to 5 and 29 to 33) during concurrent radio-chemotherapy with carboplatin (70 mg/m2, day 1 to 5 and 29 to 33)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (no amifostine)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Amifostine
Number of subjects: 28
Study: 8969478

Group type: EXPERIMENTAL
Intervention: Correlational method to estimate listener's weighting function for speech
Number of subjects: 3
Study: 1988577

Group type: EXPERIMENTAL
Intervention: FEC 50 (5FU 500 mg/m2, cyclophosphamide 500 mg/m2, epirubicin 50 mg/m2)
Number of subjects: 412

Group type: EXPERIMENTAL
Intervention: FEC 75 (5FU 500 mg/m2, cyclophosphamide 500 mg/m2, epirubicin 75 mg/m2)
Number of subjects: 412

Group type: COMPARATOR
Intervention: Epirubicin alone (75 mg/m2)
Number of subjects: 412

Group type: EXPERIMENTAL
Intervention: FEC 75
Number of subjects: 412

Group type: EXPERIMENTAL
Intervention: FEC 50
Number of subjects: 412

Group type: COMPARATOR
Intervention: Epirubicin alone
Number of subjects: 412
Study: 7081136

Group type: COMPARATOR
Intervention: DA (dibromodulcitol + Adriamycin)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: DAT (dibromodulcitol + Adriamycin + tamoxifen)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: DATN (dibromodulcitol + Adriamycin + tamoxifen for patients < 50 years)
Number of subjects: 135
Study: 30909079

Group type: EXPERIMENTAL
Intervention: Culturally informed brief motivational intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard brief intervention for alcohol use
Number of subjects: 0
Study: 30074491

Group type: EXPERIMENTAL
Intervention: Continuous venovenous hemofiltration-high cutoff
Number of subjects: 76

Group type: COMPARATOR
Intervention: Continuous venovenous hemofiltration-standard
Number of subjects: 76
Study: 26717887

Group type: EXPERIMENTAL
Intervention: Dexamethasone/Vincristine (Dx/VCR) trial
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 6-mercaptopurine (6MP) trial
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PEG-asparaginase (ASP) trial
Number of subjects: 0
Study: 24515544

Group type: EXPERIMENTAL
Intervention: Cystoscopic onabotulinum toxin A injection and oral placebo medication
Number of subjects: 155

Group type: COMPARATOR
Intervention: Cystoscopic placebo injection and active oral medication
Number of subjects: 155
Study: 22113254

Group type: EXPERIMENTAL
Intervention: Breast conservation therapy (BCT)
Number of subjects: 237

Group type: COMPARATOR
Intervention: Mastectomy (MRM)
Number of subjects: 237
Study: 19823974

Group type: EXPERIMENTAL
Intervention: Coping intervention (specific details not provided)
Number of subjects: 265

Group type: COMPARATOR
Intervention: Baseline questionnaire (prior to being informed of genetic risk)
Number of subjects: 265
Study: 18219956

Group type: EXPERIMENTAL
Intervention: Simvastatin (40 mg per day)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control group (standard therapy)
Number of subjects: 108